Published in
American Society for Microbiology, Journal of Clinical Microbiology, 8(57), 2019
DOI: 10.1128/jcm.00762-19
Links
Tools
Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic
Journal article published in 2019 by
Ramona Tavares Daltro,
Leonardo Maia Leony,
Natália Erdens Maron Freitas,
Ângelo Antônio Oliveira Silva,
Emily Ferreira Santos,
Rodrigo Pimenta Del-Rei,
Maria Edileuza Felinto Brito,
Sinval Pinto Brandão-Filho 
,
Yara Miranda Gomes,
Marcelo Sousa Silva,
Silvia Tavares Donato,
Selma Maria Bezerra Jeronimo,
Gloria Regina de Góis Monteiro,
Lucas Pedreira Carvalho,
Andréa Santos Magalhães
and other authors.
,
Yara Miranda Gomes,
Marcelo Sousa Silva,
Silvia Tavares Donato,
Selma Maria Bezerra Jeronimo,
Gloria Regina de Góis Monteiro,
Lucas Pedreira Carvalho,
Andréa Santos Magalhães
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 
Abstract
Chimeric T. cruzi antigens have been proposed as a diagnostic tool for chronic Chagas disease (CD) in both settings where Chagas disease is endemic and those where it is not endemic. Antibody response varies in accordance to each T. cruzi strain, presenting challenges to the use of antigens lacking demonstrated cross-reactivity with Leishmania spp.